An Adult Spasticity Registry of OnabotulinumtoxinA Treatment

Study Identifier
GMA-BTX-SP-12-001
CT.gov Identifier
NCT01930786
EudraCT Identifier
Not available
EUCTIS ID
Not available
For general inquiries, please contact

844-663-3742 or [email protected]

Study Complete

Study Details

Medical Condition
  • Movement Disorders - Other
    • Study Drug
  • onabotulinumtoxinA
    • Phase
    N/A
    Sex
    Female & Male
    Age
    18+ years
    Inclusion and Exclusion Criteria
    Inclusion Criteria:
    * Treatment with onabotulinumtoxinA according to the decision of the physician for spasticity * Willingness to complete study questionnaires and answer study questions by phone or internet
    Exclusion Criteria:
    * Concurrent participation in a clinical trial for spasticity

    Protocol Summary

    This is a registry study in adults with spasticity to determine onabotulinumtoxinA use in clinical practice. Treatment will be administered in accordance with physician standard practice. All treatment decisions lie with the physician.

    Study Locations

    Location
    Status
    Location
    Loma Linda University School Of Medicine
    Loma Linda, California, United States, 92350
    Status
    Not applicable
    Location
    MS Center of California
    Newport Beach, California, United States, 92663
    Status
    Not applicable
    Location
    Sutter Health General Hospital
    Sacramento, California, United States, 95816
    Status
    Not applicable
    Location
    Design Neuroscience Center
    Doral, Florida, United States, 33172
    Status
    Not applicable
    Location
    Brooks Rehabilitation Hospital
    Jacksonville, Florida, United States, 32216
    Status
    Not applicable
    Location
    Emerald Coast Center for Neurological Disorders
    Pensacola, Florida, United States, 32514
    Status
    Not applicable
    Showing {first} - {last} of {total} Results